Riskpilot← Back to searchSign inGet full accessPharmacy Stockholm AB
ABActiveOrg 5567366017Dalagatan 13Graphic design and visual communication activities · NACE 7412Est. 20071 employees
Revenue 2025
SEK 2M
+80% vs 2024
EBITDA margin
35.9%
+575% vs 2024
Equity ratio
52.8%
Financial strength
Net profit 2025
SEK -512K
-765% vs 2024
| Revenue | SEK 2M | +80% |
| EBITDA | SEK 716K | +575% |
| Net profit | SEK -512K | -765% |
| Total assets | SEK 619K | -46% |
| Equity | SEK 327K | -70% |
| Employees | 1 | — |
Legal name
Pharmacy Stockholm AB
Org number
5567366017
Legal form
Aktiebolag
NACE code
7412 · Graphic design and visual communication activities
Founded
28 augusti 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom reklam, design, arkitektur, mode, fotografering och musikproduktion, formgivning av grafiska identiteter och förpackningar åt läkemedelsindustrin samt annan därmed förenlig verksamhet.
Address
Dalagatan 13
Email
info@pharmacysthlm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 333 | 1 452 | 1 153 | 1 106 | 1 994 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 230 | 276 | 379 | 106 | 716 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 230 | 276 | 379 | 106 | 716 |
| Net financials | — | — | — | −5 | −2 141 |
| Profit before tax | 230 | 276 | 378 | 102 | −355 |
| Tax | −53 | −58 | −80 | −25 | −157 |
| Net profit | 177 | 218 | 298 | 77 | −512 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 499 | 1 538 | 1 399 | 1 152 | 619 |
| Equity | 1 336 | 1 264 | 1 262 | 1 108 | 327 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 163 | 274 | 137 | 43 | 292 |
| Total debt | 163 | 274 | 137 | 43 | 292 |
EBITDA margin
35.9%
This company
15.8%
Market median
+127% vs market
20212025
Equity ratio
52.8%
This company
38.2%
Market median
+38% vs market
20212025
Return on equity
-156.6%
This company
18.4%
Market median
-951% vs market
20212025
Net profit margin
-25.7%
This company
8.1%
Market median
-417% vs market
20212025
Asset turnover
3.22×
This company
1.12×
Market median
+188% vs market
20212025
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmacy Stockholm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Anders Lindgren | Board of Directors | 0 companies |
| Ninnie Regina Caroline Lahnborg | Deputy Board Member | 0 companies |